chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Headache
Clinical narrative: Case number PHHY2016US027962, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS, reference number: 612573) website on 29 Feb 2016. This report refers to a 60 years old female patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with first dose of FLUVIRIN (batch number: 158301) intramuscularly in to right arm on 01 Dec 2015. The patient was recommended to remain seated for 15 minutes after vaccination. Immediately after administration for a few minutes the patient felt fine, however about 15 minutes after vaccination the patient was feeling dizzy with a headache. The patient was recommended to remain seated longer and asked if she was diabetic, the patient stated no. The patient did not eat lunch so she was provided the orange juice. The patient was followed up with in an hour and the patient reported that her symptoms subsided and was doing well. The outcome of the events was reported as condition improving. Seriousness of the events was reported as non serious and causality not reported.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Myalgia
Clinical narrative: Case number PHHY2016US030161, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 612799) on 29 Feb 2016. This report refers to a 53 years old female patient. The patient had no medical history and current illness. Concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 157603) intramuscularly into left arm on 14 Oct 2015. On the same day after vaccination the patient complains of injection site pain and muscle pain. The case was assessed as non-serious. Outcome and causality of the events was not reported.
Age: 22.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pruritus
Clinical narrative: Case number PHHY2016US027309, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 613016) website on 19 Feb 2016. This report refers to 22 years old female patient. Current condition included headaches and nausea. Past medical history included depression, anxiety and dysmenorrhea. Concomitant medication included Prenatal vitamins. She was vaccinated FLUVIRIN (batch number: 1516601) intramuscularly into left arm 20 Nov 2015. On same day, after flu vaccine was given, she complained of itching at the injection site approximately 10 min after injection. She was given an ice pack for the same. The outcome of the event was complete recovery. The seriousness of the event was reported as non serious. The causality of the event was not reported.
Age: 56.0
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: Case number PHHY2016US011937 is an initial spontaneous report received via Vaccine Adverse Events Reporting System (VAERS reference number: 613100) on 18 Jan 2016. This report refers to a 56 year old male patient. His medical history and current condition were not reported. His concomitant medication was unknown. He was vaccinated with FLUVIRIN (batch number: 1514601) intramuscularly in the left arm on 20 Sep 2015. On 22 Sep 2015, the patient experienced tingling from shoulder to fingers that was extremely painful. The pain was not relieved with over the counter (OTC) medications or muscle rubs. It was reported that other family members who received vaccine on the same day were not affected. The final outcome of the events was reported as unknown. The events were reported as non-serious. Causality of the events was not reported.
Sex: F
Vaccine: FLU3
Symptoms: Administration site pain, Pain in extremity
Clinical narrative: Case number PHHY2016US031025 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 613168) on 29 Feb 2016. This report refers to a 61 year old female patient. Medical history was not reported. Concomitant medication included Vagifem, Diltiazem, XANAX, Losartan, HCTX, and Levothyroxine. It was reported that she was feeling healthy. The patient was vaccinated with FLUVIRIN (batch number: 157604) intramuscularly into left arm on 16 Nov 2015. On the same day, the patient experienced pain at administration site and all the way down arm. The outcome of the events was reported as unknown. Events were reported as non-serious. Causality of the events was not reported.
Age: 35.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site urticaria
Clinical narrative: Case number PHHY2016US031568 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 613188) on 29 Feb 2016. This report refers to a 35 year old female patient. Medical history was not reported. Her concurrent condition included allergies. Concomitant medications included CLARITIN and Albuterol. The patient was vaccinated with FLUVIRIN (batch number: 157104) intramuscularly into left arm on 30 Nov 2015. On an unknown date, the patient developed hives around injection site. The outcome of the events was reported as complete recovery. Events were reported as non-serious. Causality of the events was not reported.
Age: 49.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Chills, Pain, Skin warm, Swelling
Clinical narrative: Case number PHHY2016US027100 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 613285) on 29 Feb 2016. This report refers to a 49 year old male patient. Medical history was not reported. Her concurrent condition included seizure disorder which was defined as epilepsy/grand mal. Lab data was reported as none. Concomitant medication included DILANTIN (100 mg, 5 per day). The patient was vaccinated with FLUVIRIN (batch number: 157102) and PNEUMOVAX (other manufacturer, batch number: L035686) both intramuscularly into left arm on 03 Dec 2015. On 04 Dec 2015, around 2:30 am, the patient experienced swelling with fever in the injected arm followed by deep pain and chills. Following the events he visited emergency room on the same day. It was reported that the patient felt 75% better on 05 Dec 2015. The final outcome of the events was reported as complete recovery. Events were reported as non-serious. Causality of the events was not reported.
Age: 59.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Case number PHHY2016US029654, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 613320) website on 29 Feb 2016. This report refers to a 59 years old female patient. Past medication included as sulfa, codeine (manufacturer unknown) and indomethacin (manufacturer unknown). Concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 158001) in left arm on 03 Dec 2015. On the same day, the patient had welts on her abdomen 5 hours after the vaccination. The patient was treated with diphenhydramine (manufacturer unknown) at a dose of 75 mg for two days to relieve symptoms. The outcome of the event was reported as condition unchanged. The seriousness of the event was reported as non serious. The causality of the event was not reported.
Age: 61.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Case number OHHY2016US030275, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number 613328) website on 29 Feb 2016. This report refers to a 61-year-old female patient. Medical history and current illness were none. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 15722P) intramuscularly and ZOSTAVAX (batch number: L012478) subcutaneously on 03 Dec 2015. On 04 Dec 2015, the patient developed rash and red, itchy spots after getting ZOSTAVAX vaccine. Lab data reported was none. Final outcome of the events was recovered. Events were reported as non-serious and causality of the events was not reported.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Pain in extremity, Paraesthesia
Clinical narrative: Case number PHHY2016US028055, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 613416) website on 29 Feb 2016. This report refers to 52 years old female patient. Current condition included hypertension and Sulfa/sulfonamide allergy. Past medical history was not reported. Concomitant medications included Lorazepam (manufacturer unknown) and Lisinopril (manufacturer unknown). She was vaccinated with FLUVIRIN (batch number: 1518101) on 07 Nov 2015, on left arm. On same day, her arm had muscle pain at the injection site after vaccination that worsened days later resulting in tingling down the arm and to the right pinky finger. The arm was painful to lay on. She has not seen a doctor about it yet. The outcome of the events was condition unchanged (not recovered). The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: F
Vaccine: FLU3
Symptoms: Influenza like illness, Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: Case number PHHY2016US029137, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 613430) website on 29 Feb 2016. This report refers to 51 years old female patient. Past medical history and concomitant medication was not reported. She was vaccinated with FLUVIRIN (batch number: 15721P) on 07 Nov 2015, intramuscularly on left arm. On same day, it swelled up around injection site, it became red and hardened. It stayed like that for about 2 weeks. She also experienced flu like symptoms. The outcome of the events was complete recovery. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: Case number PHHY2016US028863, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 613707) website on 29 Feb 2016. This report refers to 33 years old female patient. Current condition included food allergies and latex. Past medical history was not reported. Concomitant medications included levothyroxine (manufacturer unknown) and prenatal vitamin. She was vaccinated with FLUVIRIN (batch number: 1515101) on 23 Nov 2015, intramuscularly on left arm. On 24 Nov 2015, she had hives and itching 11 to 12 hours post injection. She took BENADRYL 1 dose, 6 hours post BENADRYL she developed rash and itching and BENADRYL was repeated. The outcome of the events was complete recovery. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Case number PHHY2016US028942, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 613921) website on 29 Feb 2016. This report refers to 54 years old male patient. Past medical history and concomitant medication was not reported. He was vaccinated with FLUVIRIN (batch number: 158201) intramuscularly in the left arm on 22 Nov 2015. On 23 Nov 2015, he had pain in arm. The outcome of the event was reported complete recovery. The seriousness of the event was reported as non serious. The causality of the event was not reported.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: Case number PHHY2016US029043, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 614195) website on 29 Feb 2016. This report refers to 50 years old female patient. Past medical history and concomitant medication was not reported. She was vaccinated with FLUVIRIN (batch number: 158005) on 26 Oct 2015, on left arm. On an unknown date, she experienced pain/ soreness at the injection site 40 days after the injection. She said it was getting worse, not better. The final outcome of the event was unknown. The seriousness of the event was reported as non serious. The causality of the event was not reported.
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Rash
Clinical narrative: Case number PHHY2016US029110, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 614346) website on 29 Feb 2016. This report refers to 53 years old female patient. Past medications included penicillin (manufacturer unknown), sulfa, codeine and 5HT1 agonist. Past medical history and concomitant medication was not reported. She was vaccinated with FLUVIRIN (batch number: 158302) intramuscularly on left arm on 30 Nov 2015. On 01 Dec 2015, she experienced rash and itching. It was unknown if it was related to vaccine or hotel stay. The outcome of the events was unknown. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 53.0
Sex: M
Vaccine: FLU3
Symptoms: Pruritus, Rash
Clinical narrative: Case number PHHY2016US028417, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 614348) on 29 Feb 2016. This report refers to a 53 years old male patient. Medical history and current illness were none. Concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 158302) intramuscularly into left arm on 30 Nov 2015. On an unknown date after vaccination the patient experienced rash and itching. The case was assessed as non-serious. Outcome and causality of the events were unknown.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Rash erythematous
Clinical narrative: Case number PHHY2016US028421, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 614675) on 29 Feb 2016. This report refers to a 53 years old female patient. Medical history was not reported. Concurrent conditions were none. Concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1516501) intramuscularly into left arm on 19 Nov 2015. On 22 Nov 2015, three days after vaccination, the patient broke out with red bumps. Outcome of the events was reported as condition unchanged. The case was assessed as non-serious. Causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: FLU3, HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site induration, Injection site warmth, Pain
Clinical narrative: Case number PHHY2016US028158, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 615008) website on 29 Feb 2016. This report refers to 11 years old male patient. Current condition included seasonal allergies, intermittent asthma, possible cat scratch and mass (lymph node in left inner bicep area the responded quickly to SEPTRA). Past medication history was not reported. Concomitant  medication was SEPTRA. He was vaccinated with fourth dose of FLUVIRIN (batch number: 157803) on 08 Dec 2015, intramuscularly into left arm. On same day, he was also vaccinated with GARDASIL (batch number: L010596) intramuscularly into right arm, MENACTRA (batch number: U5172AA) intramuscularly into right arm and ADACEL (batch number: U5214AA) intramuscularly into left arm. On 09 Dec 2015, left deltoid (injection) site became red, warm covering complete deltoid with induration on upper half of deltoid and hurt to raise left arm more than parallel to floor. BACTRIM was started later on the day of immunization were given. The outcome of the events was complete recovery. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2016US029277, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 615030) website on 29 Feb 2016. This report refers to 49 years old male patient. Current condition included allergic to BENADRYL. Past medical history was not reported. Concomitant medication included NOVOLOG, LANTUS and ibuprofen (manufacturer unknown). She was vaccinated with FLUVIRIN (batch number: 15754P) intramuscularly into left arm on 14 Dec 2015. On same day, he experienced quarter size raised skin area at site of injection with small amount of redness. The outcome of the events was complete recovery. The seriousness of the events was reported as non serious and causality was not reported.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: Case number PHHY2016US029918, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 615603) website on 29 Feb 2016. This report refers to a 54 years old female patient. Current condition included hypothyroidism. Past medical history was not reported. Concomitant medication included levothyroxine (manufacturer unknown). She was vaccinated with FLUVIRIN (batch number: 157404) on left arm on 15 Sep 2015. On 16 Sep 2015 (day after receiving vaccine), it was hard to lift her left arm and she experienced soreness. Hard to lift arm and soreness was still there. Final outcome of the events was reported as unknown. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 69.0
Sex: F
Vaccine: FLU3, VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: Case number PHHY2016US029265, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 615632) website on 29 Feb 2016. This report refers to 69 year old female patient. Medical history was not reported. Concurrent conditions included hypercholesterolemia and hypertension. The patient was vaccinated with FLUVIRIN (batch number: 1515901) intramuscularly in the left arm and ZOSTAVAX (batch number: L017165) subcutaneously in the right arm both received on 14 Dec 2015. On 15 Dec 2015, the patient experienced red, hard and swelling at injection site. She did not experience any pain or pruritus at the site and she noticed it when dressing the hard spot. Through the day it increased in size to that of a half dollar. Patient took diphenhydramine to alleviate symptoms. The symptoms resolved and as of 18 Dec 2015 afternoon the site had nearly returned to normal. Outcome of the events was reported as complete recovery. Seriousness of the events was reported as no serious and causality of the events was not reported.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2016US029971, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 615685) website on 29 Feb 2016. This report refers to 61 years old female patient. Past medical history and concomitant medication was not reported. She was vaccinated with FLUVIRIN (batch number: 158203) on 11 Dec 2015, on left arm. On 12 Dec 2015, it was hurtful, red and swollen at the site of injection. It was warm and swollen. The outcome of the events was complete recovery. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Case number PHHY2016US023872, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 615887) on 19 Feb 2016. This report refers to a 56 years old female patient. Medical history and current illness were none. Concomitant medications were none. The patient was vaccinated with FLUVIRIN (batch number: 158005) intramuscularly into right arm on 03 Dec 2015 with no outstanding observations. On 04 Nov 2015 the patient experienced pain in vaccine administered arm. The patient did not report any swelling, redness, or itchiness in arm. The patient reported to pharmacy on 22 Dec 2015 complaining of continuing pain in vaccine administered arm. Final outcome of the event was unknown. The case was assessed as non-serious. Causality of the event was not reported.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Blood creatine phosphokinase normal, C-reactive protein normal, Full blood count normal, Myalgia, Red blood cell sedimentation rate normal
Clinical narrative: Case number PHHY2016US028091, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 616505) website on 29 Feb 2016. This report refers to a 34-years-old-female patient. Past medical history was not reported. Concomitant medications included Paroxetine (manufacturer unknown) and Lorazepam (manufacturer unknown). The patient was vaccinated with FLUVIRIN (batch number: 1516601) intramuscularly in right arm on 22 Nov 2015. On the same day, the patient experienced deltoid pain and muscle pain. Laboratory data included ultra sound scan, complete blood count (CBC), creatinine kinases (CK), erythrocyte sedimentation rate (ESR) and C reactive protein tests, all the test results were normal (result details unspecified). The patient was treated with ibuprofen (manufacturer unknown). The outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Ultrasound scan normal
Clinical narrative: Case number PHHY2016US028091, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 616505) website on 29 Feb 2016. This report refers to a 34-years-old-female patient. Past medical history was not reported. Concomitant medications included Paroxetine (manufacturer unknown) and Lorazepam (manufacturer unknown). The patient was vaccinated with FLUVIRIN (batch number: 1516601) intramuscularly in right arm on 22 Nov 2015. On the same day, the patient experienced deltoid pain and muscle pain. Laboratory data included ultra sound scan, complete blood count (CBC), creatinine kinases (CK), erythrocyte sedimentation rate (ESR) and C reactive protein tests, all the test results were normal (result details unspecified). The patient was treated with ibuprofen (manufacturer unknown). The outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Vaccination site pain
Clinical narrative: Case number PHHY2016US029973, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS ID: 616507) website on 29 Feb 2016. This report refers to a 63 years old female patient. Past medical history and concomitant medication were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1518001) intramuscularly in to left arm on 02 Nov 2015. On same day after vaccination, the patient experienced pain and soreness at site of vaccination. The patient visited emergency room on an unknown date. It was reported that the patient would go to get X-ray. The final outcome of the event was reported as condition unchanged. Seriousness of the event was reported as non serious and causality not reported.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Case number PHHY2016US029886, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 616515) on 29 Feb 2016. This report refers to a 61 years old female patient. Past medical history included chronic pain, depression and insomnia. Current conditions included hypertension, fibromyalgia and restless leg syndrome. Concomitant medication was not reported. She was vaccinated with FLUVIRIN (batch number: 157004) into the left arm on 21 Sep 2015. She experienced pain in the left arm since getting flu shot (date unspecified). She received treatment with ketorolac pills and shots, prednisone (manufacturer unknown) and dilaudid (manufacturer unknown). She felt better after shoulder injection. The outcome of the event was reported as complete recovery on an unknown date. The event was assessed as non serious and causality was not reported.
Age: 49.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: Case number PHHY2016US031712, is an initial spontaneous report received from the Vaccine Adverse Event  Reporting System (VAERS reference number: 616621) website on 29 Feb 2016. This report refers to a 49-years-old female patient. Past medical history included as, high cholesterol, dermatosis papulosa nigra (DPN), depression and hyperthyroid. Current conditions included as diabetes mellitus (DM) and codeine allergy. Concomitant medications included insulin (manufacturer unknown), gabapentin (manufacturer unknown), gemfibrozil (manufacturer unknown), levothyroxine (manufacturer unknown), simvastatin (manufacturer unknown), tramadol (manufacturer unknown), trazodone (manufacturer unknown). The patient was vaccinated with FLUVIRIN (batch number: 1516401) intramuscularly in left arm along with ADACEL (manufacturer unknown, batch number: U5235AA) intramuscularly in right arm, both on 06 Oct 2015. On the same date, the patient developed left (L) arm pain and limited arm use after vaccine. There was no weakness or numbness and she was referred for physical therapy. The outcome of the events was reported as condition unchanged on an unknown date. The seriousness of the events was reported as non serious. The causality of the events was not reported.
Age: 68.0
Sex: M
Vaccine: FLU3, PNC13, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2016US030233, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS ID: 616761) website on 29 Feb 2016. This report refers to a 68 years old male patient. Historical condition was not reported. Current conditions included HIV, high cholesterol and diabetes. Concomitant medication included atorvastatin (manufacturer unknown), metformin (manufacturer unknown), glipizide ER (manufacturer unknown), ATRIPLA. The patient was vaccinated with FLUVIRIN (batch number: 1516501), PREVNAR 13 ((other manufacturer), batch number: M27554) both intramuscularly into left arm and varicella zoster vaccine (other manufacturer, batch number: L032403) subcutaneously in to right arm, all on 22 Dec 2015. On 23 Dec 2015 after vaccination, the patient experienced red, swollen and painful upper left arm. It was reported that the patient would be evaluated by primary care physician. The final outcome of the events was reported as unknown. Seriousness of the events was reported as non serious and causality not reported.
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema
Clinical narrative: Case number PHHY2016US029804, is an initial spontaneous report received Vaccine Adverse Event Reporting System (VAERS, reference number: 616830) website on 29 Feb 2016. This report refers to a 63 years old female patient. Past medical history was not reported. Current condition included as diabetes, hypothyroid and hypertension. Concomitant medications was not reported. The patient was vaccinated with FLUVIRIN (batch number: 1516601) into left arm (left deltoid), intramuscularly on 28 Dec 2015. On 29 Dec 2015, the patient experienced two inch diameter redness at injection site, left deltoid, otherwise patient is asymptomatic. The outcome of the event was reported as condition unchanged. The seriousness of the event was reported as non serious. The causality of the event was not reported.
Sex: F
Vaccine: FLU3
Symptoms: Headache, Injection site pain, Pain
Clinical narrative: Case number PHHY2016US029626, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 616860) on 29 Feb 2016. This report refers to a 64 years old female patient. Past medical history was not reported. Concomitant medication included alendronate (manufacturer unknown) 70 mg tablet, hydrochlorothiazide (manufacturer unknown) 25 mg tablet, lovastatin (manufacturer unknown) 20 mg tablet, metformin (manufacturer unknown) 500 mg tablet, NORVASC 10 mg tablet and metoprolol tartrate (manufacturer unknown) 25 mg tablet. She was vaccinated with first dose of FLUVIRIN (batch number: 157603) intramuscularly into right arm on 18 Nov 2015. After vaccination, on the same day, she experienced soreness where the shot was given, headache and aches. The outcome of the events was reported as unknown. The events were assessed as non serious and causality was not reported.
Age: 15.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema
Clinical narrative: Case number PHHY2016US029957, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS ID: 616957) website on 29 Feb 2016. This report refers to a 15 years old female patient. Historical condition included bipolar. Concomitant medication included ABILIFY. The patient was vaccinated with FLUVIRIN (batch number: 1515201) intramuscularly into right arm on 29 Dec 2015. On 31 Dec 2015 after vaccination, the patient experienced redness at site of vaccination. The final outcome of the event was reported as complete recovery. Seriousness of the event was reported as non serious and causality not reported.
Age: 80.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: Case number PHHY2016US032650, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 617001) on 29 Feb 2016. This report refers to an 80 year old male patient. Historical condition included atrial fibrillation. Current condition included diabetes. Concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 1516901) intramuscularly in left arm on 15 Dec 2015. On 31 Dec 2015, the patient developed pain at the site of injection. The outcome of the event was reported as condition unchanged. Event was reported as non-serious. Causality of the event was not reported.
Age: 17.0
Sex: M
Vaccine: FLU3
Symptoms: Rash
Clinical narrative: Case number PHHY2016US035335, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 617193) on 15 Mar 2016. This report refers to a 17 year old male patient. Medical history and concomitant medication of the patient were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1516901) in left arm on 15 Nov 2015. On 17 Nov 2015, the patient developed rash. Outcome of the event was reported as complete recovery. Event was reported as non-serious. Causality was not reported.
Sex: F
Vaccine: FLU3
Symptoms: Myalgia, Pain
Clinical narrative: Case number PHHY2016US034542, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 617706) website 15 Mar 2016. This report refers to 47 years old female patient. Current conditions included degeneration of lumbar intervertebral disc and spondyloarthropathy. Past medical history included migraines, obese, primary fibromyalgia syndrome, restless legs and sleep apnea. Concomitant medication was not reported. She was vaccinated with FLUVIRIN (batch number: not reported), intramuscularly on 03 Dec 2015. On the same day after vaccination, she had pain in right deltoid when lifting her arm or bearing weight. Pain was worse when she moved arm back. Pain was very sharp, pin pointed pain, which was better with rest. The final outcome of the event was not reported. The seriousness of the event was reported as non serious and causality was not reported.
Age: 65.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Dizziness, Injection site induration, Injection site swelling, Pruritus, Pyrexia
Clinical narrative: Case number PHHY2016US034587, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 618191) website on 15 Mar 2016. This report refers to 65 years old female patient. Past drug included Aspirin. Past medical history was not reported. Concomitant medications included metformin (manufacturer unknown), losartan (manufacturer unknown), ZEGERID and simvastatin (manufacturer unknown). She was vaccinated with FLUVIRIN (batch number: 158101), intramuscularly on left arm and PREVNAR 13 (batch number: M1625E), intramuscularly on left arm, both received on 04 Jan 2016. On the same day after vaccination, she had fever for 2 days, itching, swelling of the injection site, injection site induration and some dizziness when she arrived home. Final outcome of the events was reported as condition unchanged. The seriousness of the events was reported as non serious and causality was not reported.
Sex: F
Vaccine: FLU3, PPV, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Case number PHHY2016US035327, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 618246) website on 15 Mar 2016. This report refers to 56 years old female patient. Current conditions included allergy to morphine and ALEVE and very sensitive to vaccines. Past medical history and concomitant medication was not reported. She was vaccinated with FLUVIRIN (batch number: 1516601), on right arm; with PNEUMOVAX (other manufacturer, batch number: K008927), on left arm and with ZOSTAVAX (other manufacturer, batch number: L031271), on right arm, all on 31 Dec 2015. On same day, area around where vaccine ZOSTAVAX was administered on right arm was red, swollen, painful which itched too. She said started out as large area and got better once ice was applied. The final outcome of the events was complete recovery. The seriousness of the events was reported as non serious and causality was not reported. Following an internal review done of 18 Mar 2016 for date received on 15 Mar 2016, it was identified that events occurred only with non Novartis ZOSTAVAX, so no adverse event reported FLUVIRIN, hence case would be deactivated.
Sex: U
Vaccine: FLU3, PNC13
Symptoms: Pyrexia
Clinical narrative: Case PHHY2016US030928, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 618850) on 29 Feb 2016. This report refers to a patient of an unknown age and gender. Relevant medical history, concomitant medications and past product history were not reported. Concurrent conditions were unknown. The patient was vaccinated with FLUVIRIN (batch number: not reported) and PREVNAR 13 (batch number: not reported other manufacturer); both on an unknown date. On an unknown date, following administration of the vaccinations, the patient developed a fever. Subsequently, on an unknown date, the fever resolved. The case was assessed as non-serious. Causality of the event was not reported.
Age: 63.0
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Case number PHHY2016US034749, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 619143) website on 15 Mar 2016. This report refers to 63 years old male patient. Past medical history and concomitant medication was not reported. He was vaccinated with FLUVIRIN (batch number: 1515401), on left arm on 06 Oct 2015. His arm still hurt from when he received the flu shot on 06 Oct 2015. On an unknown date, he went to emergency room. The final outcome of the event was reported as unknown. Seriousness of the event was reported as non serious and causality was not reported.
Age: 18.0
Sex: F
Vaccine: FLU3
Symptoms: Syncope
Clinical narrative: Case number PHHY2016US041428 is an initial spontaneous report received via Vaccine Adverse Events Reporting System (VAERS reference number: 620472) on 29 Mar 2016. This report refers to an 18 year old female patient. She had no medical history, current conditions or concomitant medications. She was vaccinated with FLUVIRIN (batch number: 158303) intramuscularly in the left arm on 23 Jan 2016. On the same date, about 5 minutes after vaccination, the patient developed syncope. The patient was coherent very quickly and was helped to floor by father and the reporter. The patient was placed on floor and then moved to chair. Thirty minutes later, she walked out of store with no incident. No laboratory tests were done. The events outcome was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2016US041398, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 620913) website on 29 Mar 2016. This report refers to a 36 years old female patient. The patient's concurrent conditions included diabetes mellitus and allergic to citrus fruits. The patient was in stable condition. Concomitant medication included metformin. The patient was vaccinated with FLUVIRIN (batch number: 158004) intramuscularly into left arm on 22 Jan 2016. On the same day after vaccination the patient experienced tenderness, pain and swelling on left deltoid. The patient was treated with KEFLEX 500 mg twice daily for 5 days. Outcome of the events was unknown. The case was assessed as non-serious. Causality of the events was not reported.
Age: 41.0
Sex: F
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Injected limb mobility decreased, Injection site pain, Pain in extremity
Clinical narrative: Case number PHHY2016US043934 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 621361) on 29 Mar 2016. This report refers to a 41 year old female patient. Medical history and concomitant medication was not reported. Her concurrent condition included asthma for which PNEUMOVAX was given. No lab data were reported. The patient was vaccinated with FLUVIRIN (batch number: 15721P, expiry date: 30 May 2016) and PNEUMOVAX (other manufacturer, dose: 0.5 ml, batch number: K009107, expiry date: 21 Jan 2016) both intramuscularly into left arm on 26 Sep 2015. On Oct 2015, the patient experienced pain in hand and arm where the vaccines were administered and had trouble in lifting her arm. Following the events she visited physician and sought medical attention. It was reported that the pain in hand and arm was improving but she still had trouble in lifting her arm. The final outcome of the events was reported as condition unchanged. Events were reported as non-serious. Causality of the events was not reported.
Age: 41.0
Sex: F
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Case number PHHY2016US043934 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 621361) on 29 Mar 2016. This report refers to a 41 year old female patient. Medical history and concomitant medication was not reported. Her concurrent condition included asthma for which PNEUMOVAX was given. No lab data were reported. The patient was vaccinated with FLUVIRIN (batch number: 15721P, expiry date: 30 May 2016) and PNEUMOVAX (other manufacturer, dose: 0.5 ml, batch number: K009107, expiry date: 21 Jan 2016) both intramuscularly into left arm on 26 Sep 2015. On Oct 2015, the patient experienced pain in hand and arm where the vaccines were administered and had trouble in lifting her arm. Following the events she visited physician and sought medical attention. It was reported that the pain in hand and arm was improving but she still had trouble in lifting her arm. The final outcome of the events was reported as condition unchanged. Events were reported as non-serious. Causality of the events was not reported.
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Pain, Pain in extremity, Paraesthesia
Clinical narrative: Case number PHHY2016US042681 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 621518) on 29 Mar 2016. This report refers to a female patient of an unknown age. Medical history and current illness was not reported. Concomitant medications included mupirocin ointment and ZIANA gel. The patient was vaccinated with FLUVIRIN (batch number: 157902) intramuscularly on 27 Dec 2015. On 28 Dec 2015, the patient stated that her arm was hurting since the shot and had tingling going down her arm and fingers. She could lift her arm but it was painful to lift it too high. Following the events she visited emergency room. The outcome of the events was reported as unknown. Events were reported as non-serious. Causality of the events was not reported.
Age: 76.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2016US044492, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System) VAERS reference number: 621603) website on 29 Mar 2016. This report refers to a 76 years old male patient. The patient had no known medical conditions (NKMC) and no known drug allergies (NKDA). Concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1516201) into left arm and PNEUMOVAX (batch number: L011531) into right arm; both intramuscularly on 23 Oct 2015. On the same day after vaccination the patient experienced swelling and redness in injection spot (flu shot arm). Outcome of the events was recovered. The case was assessed as non-serious. Causality of the events was not reported.
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Injection site pain
Clinical narrative: Case number PHHY2016US040766 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 622060) on 18 Mar 2016. This report refers to a 39 year old female patient. Medical history and concomitant medication was not reported. Her current illness included shoulder pain. The patient was vaccinated with FLUVIRIN (batch number: 1514701) intramuscularly into arm on 27 Sep 2015. On 28 Sep 2015, her arm was hurting where she received the vaccine. It was reported that she returned back to pharmacy in late January and the site was still hurting. The outcome of the event was reported as condition unchanged. Event was reported as non-serious. Causality of the event was not reported.
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Musculoskeletal pain, Pain
Clinical narrative: Case number PHHY2016US040766 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 622060) on 18 Mar 2016. This report refers to a 39 year old female patient. Medical history and concomitant medication was not reported. Her current illness included shoulder pain. The patient was vaccinated with FLUVIRIN (batch number: 1514701) intramuscularly into arm on 27 Sep 2015. On 28 Sep 2015, her arm was hurting where she received the vaccine. It was reported that she returned back to pharmacy in late January and the site was still hurting. The outcome of the event was reported as condition unchanged. Event was reported as non-serious. Causality of the event was not reported.
Age: 51.0
Sex: M
Vaccine: FLU3, VARZOS
Symptoms: Injection site pain, Myalgia, Pain in extremity
Clinical narrative: Case number PHHY2016US042116 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 622091) on 29 Mar 2016. This report refers to a 51 year old male patient. Medical history was not reported. His current condition included asthma. Concomitant medications included VENTOLIN, NASONEX and ADVAIR. The patient was vaccinated with FLUVIRIN (batch number: 157802) intramuscularly into right arm and ZOSTAVAX (other manufacturer, batch number: L026414) subcutaneously into left arm on 05 Dec 2015. On same day, the patient experienced injection site pain that lasted for approximately one week. It was reported that since injection he had pain that migrated around entire left arm. Also, he had deep muscle like pain which was not constant but was coming and going. The patient was treated with TYLENOL and ibuprofen but neither relieved the pain. The outcome of the events was not reported. Events were reported as non-serious. Causality of the events was not reported.
Sex: F
Vaccine: FLU3
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Case number PHHY2016US041408 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS, reference number: 622246) on 29 Mar 2016. This report refers to a 38 year old female patient. Her medical history and current conditions were not reported. Her concomitant medications included escitalopram. She was vaccinated with FLUVIRIN (batch number: 1914621) in the right arm on 10 Jan 2016. On 11 Jan 2016, the patient experienced enlarged and painful lymph nodes under armpits. The doctor was notified and the patient was informed that side effect was possible. The patient did not receive treatment and symptoms resolved after 2 weeks. The events outcome was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported.
Age: 40.0
Sex: F
Vaccine: FLU3, MMR
Symptoms: Pyrexia, Rash erythematous
Clinical narrative: Case number PHHY2016US041821 is an initial spontaneous report received via Vaccine Adverse Events Reporting System (VAERS reference number: 622275) on 29 Mar 2016. This report refers to a 40 year old female patient. Her current conditions included allergy to penicillin and gluten. She had no known concomitant medications. She was vaccinated with FLUVIRIN (batch number: 157103) intramuscularly in the left arm and MMR II (batch number: K018990) subcutaneously in the right arm; both vaccines administered on 14 Jan 2016. On 23 Jan 2016, the patient had fever q.p.m (every day after noon) through 27 Jan 2016. On 27 Jan 2016, the patient also experienced circular, red, raised rash on face, neck, trunk and extremities. She went to emergency room to the MD on 27 Jan 2016 and was given steroid. No laboratory tests were done. The outcome of the events was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported.
Age: 75.0
Sex: F
Vaccine: FLU3
Symptoms: Pain, Pain in extremity
Clinical narrative: Case number PHHY2016US043936, is an initial spontaneous report received from a consumer (patient) via Vaccine Adverse Event Reporting System (VAERS reference number: 622341) website on 29 Mar 2016. This report refers to a 75 years old female patient. The patient had no medical conditions and concurrent conditions. Concomitant medications included CARTIA and pravastatin. The patient was healthy at the time of vaccination. The patient was vaccinated with FLUVIRIN (batch number: not reported) on 05 Sep 2015. On the same day after vaccination the patient experienced pain in upper arm above elbow. Further the patient felt pain when she raises her arms. The patient never had this pain before the shots. Outcome of the events was reported as not recovered. The case was assessed as non-serious. Causality of the events was not reported.
Age: 69.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site pain
Clinical narrative: Case number PHHY2016US044480, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 622655) website on 29 Mar 2016. This report refers to a 69 years old male patient. Medical history was not reported. Concurrent conditions were none known. Concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 1517801) and PNEUMOVAX (batch number: K012424, other manufacturer); both intramuscularly on 26 Jan 2016. On the same day after vaccination the patient experience significant pain at site of injection requiring visit to ER/Orthopedist. Outcome of the event was recovered. The case was assessed as non-serious. Causality of the event was not reported.